Migrena klinikiniai tyrimai Mičiganas
6 tyrimai dėl Migrena ieško dalyvių vietose Mičiganas.
Miestai Mičiganas
Oficialus tyrimo tekstas (anglų kalba)
Study of EVO756 in Adults With Migraine
- Michigan Headache and Neurological Institute, Ann Arbor
- Quest Research Institute-Alcanza, Farmington Hills
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NRST - Detroit, Detroit
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-28 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Michigan Head Pain and Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Michigan Head Pain & Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06810505A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Michigan Headache Pain & Neurological Institute, Ann Arbor
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.